Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 46

1.

Combination Varenicline/Bupropion Treatment Benefits Highly Dependent Smokers in an Adaptive Smoking Cessation Paradigm.

Rose JE, Behm FM.

Nicotine Tob Res. 2017 Aug 1;19(8):999-1002. doi: 10.1093/ntr/ntw283.

2.

Response to Gorelick.

Rose JE, Behm FM.

Am J Psychiatry. 2015 Apr;172(4):395. doi: 10.1176/appi.ajp.2015.14111429r. No abstract available.

PMID:
25827038
3.

Sex-specific effects of cigarette mentholation on brain nicotine accumulation and smoking behavior.

Zuo Y, Mukhin AG, Garg S, Nazih R, Behm FM, Garg PK, Rose JE.

Neuropsychopharmacology. 2015 Mar;40(4):884-92. doi: 10.1038/npp.2014.263. Epub 2014 Sep 30.

4.

Combination treatment with varenicline and bupropion in an adaptive smoking cessation paradigm.

Rose JE, Behm FM.

Am J Psychiatry. 2014 Nov 1;171(11):1199-205. doi: 10.1176/appi.ajp.2014.13050595.

5.

Adapting smoking cessation treatment according to initial response to precessation nicotine patch.

Rose JE, Behm FM.

Am J Psychiatry. 2013 Aug;170(8):860-7. doi: 10.1176/appi.ajp.2013.12070919.

6.

Smoking quit success genotype score predicts quit success and distinct patterns of developmental involvement with common addictive substances.

Uhl GR, Walther D, Musci R, Fisher C, Anthony JC, Storr CL, Behm FM, Eaton WW, Ialongo N, Rose JE.

Mol Psychiatry. 2014 Jan;19(1):50-4. doi: 10.1038/mp.2012.155. Epub 2012 Nov 6.

7.

Repetitive transcranial magnetic stimulation of the superior frontal gyrus modulates craving for cigarettes.

Rose JE, McClernon FJ, Froeliger B, Behm FM, Preud'homme X, Krystal AD.

Biol Psychiatry. 2011 Oct 15;70(8):794-9. doi: 10.1016/j.biopsych.2011.05.031. Epub 2011 Jul 18.

PMID:
21762878
8.

Menthol preference among smokers: association with TRPA1 variants.

Uhl GR, Walther D, Behm FM, Rose JE.

Nicotine Tob Res. 2011 Dec;13(12):1311-5. doi: 10.1093/ntr/ntr119. Epub 2011 Jun 30.

9.

Silver acetate interactions with nicotine and non-nicotine smoke components.

Rose JE, Behm FM, Murugesan T, McClernon FJ.

Exp Clin Psychopharmacol. 2010 Dec;18(6):462-9. doi: 10.1037/a0021966.

PMID:
21186921
10.

Pulmonary delivery of nicotine pyruvate: sensory and pharmacokinetic characteristics.

Rose JE, Turner JE, Murugesan T, Behm FM, Laugesen M.

Exp Clin Psychopharmacol. 2010 Oct;18(5):385-94. doi: 10.1037/a0020834. Erratum in: Exp Clin Psychopharmacol. 2011 Feb;19(1):iii.

PMID:
20939642
11.

Genome-wide association for smoking cessation success in a trial of precessation nicotine replacement.

Uhl GR, Drgon T, Johnson C, Ramoni MF, Behm FM, Rose JE.

Mol Med. 2010 Nov-Dec;16(11-12):513-26. doi: 10.2119/molmed.2010.00052. Epub 2010 Aug 24.

12.

Hippocampal and striatal gray matter volume are associated with a smoking cessation treatment outcome: results of an exploratory voxel-based morphometric analysis.

Froeliger B, Kozink RV, Rose JE, Behm FM, Salley AN, McClernon FJ.

Psychopharmacology (Berl). 2010 Jul;210(4):577-83. doi: 10.1007/s00213-010-1862-3. Epub 2010 Apr 28.

PMID:
20424827
13.

Personalized smoking cessation: interactions between nicotine dose, dependence and quit-success genotype score.

Rose JE, Behm FM, Drgon T, Johnson C, Uhl GR.

Mol Med. 2010 Jul-Aug;16(7-8):247-53. doi: 10.2119/molmed.2009.00159. Epub 2010 Mar 17. Erratum in: Mol Med. 2012;18(1):729.

14.

Reinforcing effects of nicotine and non-nicotine components of cigarette smoke.

Rose JE, Salley A, Behm FM, Bates JE, Westman EC.

Psychopharmacology (Berl). 2010 May;210(1):1-12. doi: 10.1007/s00213-010-1810-2. Epub 2010 Apr 1.

15.

Kinetics of brain nicotine accumulation in dependent and nondependent smokers assessed with PET and cigarettes containing 11C-nicotine.

Rose JE, Mukhin AG, Lokitz SJ, Turkington TG, Herskovic J, Behm FM, Garg S, Garg PK.

Proc Natl Acad Sci U S A. 2010 Mar 16;107(11):5190-5. doi: 10.1073/pnas.0909184107. Epub 2010 Mar 8.

16.

Precessation treatment with nicotine patch significantly increases abstinence rates relative to conventional treatment.

Rose JE, Herskovic JE, Behm FM, Westman EC.

Nicotine Tob Res. 2009 Sep;11(9):1067-75. doi: 10.1093/ntr/ntp103. Epub 2009 Jun 30.

PMID:
19567826
17.

Selectively reduced responses to smoking cues in amygdala following extinction-based smoking cessation: results of a preliminary functional magnetic resonance imaging study.

McClernon FJ, Hiott FB, Liu J, Salley AN, Behm FM, Rose JE.

Addict Biol. 2007 Sep;12(3-4):503-12. Epub 2007 Jun 16.

PMID:
17573781
18.

Regional brain activity correlates of nicotine dependence.

Rose JE, Behm FM, Salley AN, Bates JE, Coleman RE, Hawk TC, Turkington TG.

Neuropsychopharmacology. 2007 Dec;32(12):2441-52. Epub 2007 Mar 14.

19.

Precessation treatment with nicotine skin patch facilitates smoking cessation.

Rose JE, Behm FM, Westman EC, Kukovich P.

Nicotine Tob Res. 2006 Feb;8(1):89-101.

PMID:
16497603
20.

Neuroactive steroids, negative affect, and nicotine dependence severity in male smokers.

Marx CE, Trost WT, Shampine L, Behm FM, Giordano LA, Massing MW, Rose JE.

Psychopharmacology (Berl). 2006 Jun;186(3):462-72. Epub 2006 Jan 10.

PMID:
16402195

Supplemental Content

Loading ...
Support Center